Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham

(NasdaqGM:PRE), The Next Big Thing in Wellness? IM8 Lands in the U.S. with a Star-Studded Launch. David Beckham and a world-class scientific team are putting the focus back on foundational health CHARLOTTE, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) — IM8, a premium supplements brand co-founded by David Beckham, hosted its U.S. unveiling event in New […]

Vemanti Group Announces Discussions Regarding Onus Finance UAB

(Other OTC:VMNT),(OTC US:VMNT), IRVINE, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Vemanti Group, Inc. (“Vemanti” or the “Company”) (OTCQB: VMNT) today announced ongoing discussions aimed at acquiring a majority control of the parent company of Onus Finance UAB (“Onus Finance”), the operator of the innovative cryptocurrency exchange platform, ONUS Pro (https//goonus.io). This strategic move aligns

HYCU(R) R-Cloud(TM) Named to TechTarget Storage Products of the Year Awards

Boston, Massachusetts, Jan. 21, 2025 (GLOBE NEWSWIRE) — HYCU, Inc., a leader for modern data protection for on-prem, cloud services, and SaaS, and one of the fastest growing companies in the industry, announced that HYCU(R) R-Cloud(TM) won Bronze in the Backup and Disaster Recovery Hardware Software and Services Category in the 23rd Annual Awards edition

NewtekOne, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025, After the Market Closes

(NasdaqGM:NEWT), BOCA RATON, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — NewtekOne, Inc. (“the Company”) (NASDAQ: NEWT) announced today that it will report its fourth quarter and full year 2024 financial results after the market closes on Wednesday, February 26, 2025. A conference call to discuss these results will be hosted by Barry Sloane, Chief Executive

D. Boral Capital Secures Strategic Investments from Global Investment Bank ARC Group and an Institutional Investor

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — D. Boral Capital, a premier investment bank focused on high-quality mid-market and growth issuers, today announced it has secured significant strategic investments from an institutional investor and ARC Group, a leading global investment bank and management consultancy firm. These partnerships position D. Boral Capital for accelerated growth

Nascent Biotech Receives Delinquency Notification Related to its Delayed September 30, 2024 Financial Filing

(OTCQB:NBIO),(OTC US:NBIO), NORTH PALM BEACH, FL, Jan. 21, 2025 (GLOBE NEWSWIRE) — Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage biotechnology company developing monoclonal antibodies targeting various cancer types, today announced that it has received a written notification from the OTC Markets Group as a result of its failure to file

Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology

(TSX-V:KNE),(OTC US:KNBIF),(Other OTC:KNBIF), WINNIPEG, Manitoba, Jan. 21, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday, January 23, 2025 at 4:15pm Eastern Time. Participants can register for the webinar by using this link: Kane Webinar – Jan 23, 2025 Marc Edwards, President and

Blum Holdings, Inc. Announces Strategic Financing and Intended Acquisitions

(Other OTC:BLMH),(OTC US:BLMH), DOWNEY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blum”, “Blum Holdings,” “we” or “us”), a California-based cannabis operator, today announced the receipt of $900,000 in financing led by Mr. Douglas Rosenberg. This capital will support operational and acquisition-related activities in 2025. Mr. Rosenberg is the

Adaptive Research Expands into Psychiatry with Addition of Prodigy Psychiatric Group to Clinical Trial Network

SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) — Adaptive Research Inc. announced that Prodigy Psychiatric Group has joined its clinical trial network, marking Adaptive Research's expansion into psychiatric research. This addition will enable clinical trials access for patients seeking mental health treatment in community settings. “We welcome Prodigy Psychiatric Group as we extend our network

Scroll to Top